ArticleCancer immunology, immunotherapy : CII2005

Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.